Drawing for PILLEX

USPTO serial 98650327

PILLEX

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
MASON, JARED MICHAEL
Law office
TMO LAW OFFICE 119

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PILLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

C. Blair Barbieri

C. Blair Barbieri Hovey Williams LLP10801 Mastin Blvd., Suite 1000Overland Park, KS 66210United States

Goods and services

ClassDescriptionStatusFirst use
021All purpose portable household containers; Medication containers for personal use; Pill boxes for personal use for organizing and dispensing pills and capsules; Plastic storage containers for household or domestic use; Plastic storage containers for household useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 24, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 24, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 23, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 23, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 22, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 22, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jan 22, 2025CNSLSUSPENSION LETTER WRITTEN—
Jan 22, 2025DOCKASSIGNED TO EXAMINER—
Jan 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance